- Home
- CVKD vs WLGS Comparison
CVKD vs WLGS Comparison
Compare CVKD & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- WLGS
- Stock Information
- Founded
- CVKD 2022
- WLGS 1981
- Country
- CVKD United States
- WLGS Hong Kong
- Employees
- CVKD N/A
- WLGS N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- WLGS Engineering & Construction
- Sector
- CVKD Health Care
- WLGS Consumer Discretionary
- Exchange
- CVKD Nasdaq
- WLGS Nasdaq
- Market Cap
- CVKD 17.1M
- WLGS 22.2M
- IPO Year
- CVKD 2023
- WLGS 2023
- Fundamental
- Price
- CVKD $15.24
- WLGS $2.48
- Analyst Decision
- CVKD Strong Buy
- WLGS
- Analyst Count
- CVKD 2
- WLGS 0
- Target Price
- CVKD $52.50
- WLGS N/A
- AVG Volume (30 Days)
- CVKD 59.6K
- WLGS 254.3K
- Earning Date
- CVKD 11-08-2024
- WLGS 11-01-2024
- Dividend Yield
- CVKD N/A
- WLGS N/A
- EPS Growth
- CVKD N/A
- WLGS N/A
- EPS
- CVKD N/A
- WLGS N/A
- Revenue
- CVKD N/A
- WLGS $6,825,879.00
- Revenue This Year
- CVKD N/A
- WLGS N/A
- Revenue Next Year
- CVKD N/A
- WLGS N/A
- P/E Ratio
- CVKD N/A
- WLGS N/A
- Revenue Growth
- CVKD N/A
- WLGS 63.69
- 52 Week Low
- CVKD $5.40
- WLGS $0.40
- 52 Week High
- CVKD $32.55
- WLGS $4.20
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- WLGS 61.00
- Support Level
- CVKD $11.19
- WLGS $2.33
- Resistance Level
- CVKD $15.93
- WLGS $4.20
- Average True Range (ATR)
- CVKD 1.36
- WLGS 0.64
- MACD
- CVKD 0.23
- WLGS 0.07
- Stochastic Oscillator
- CVKD 61.01
- WLGS 38.57
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.